These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37492136)

  • 1. An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.
    Acuña-Castillo C; Barrera-Avalos C; Bachelet VC; Milla LA; Inostroza-Molina A; Vidal M; Luraschi R; Vallejos-Vidal E; Mella-Torres A; Valdés D; Reyes-López FE; Imarai M; Rojas P; Sandino AM
    Front Public Health; 2023; 11():1191377. PubMed ID: 37492136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
    Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
    Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
    Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
    BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 reinfections in Mexico City: implications for public health.
    de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
    Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile.
    Acuña-Castillo C; Vidal M; Inostroza-Molina A; Vallejos-Vidal E; Luraschi R; Figueroa M; Barrera-Avalos C; Vera R; Vargas S; Valdes D; Maisey K; Imarai M; Leiva-Salcedo E; Escobar A; Reyes-Cerpa S; Gaete A; Palma-Vejares R; Travisany D; Rojo LE; Reyes-López FE; Sandino AM
    J Environ Public Health; 2022; 2022():3859071. PubMed ID: 35528635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.
    Wei J; Stoesser N; Matthews PC; Khera T; Gethings O; Diamond I; Studley R; Taylor N; Peto TEA; Walker AS; Pouwels KB; Eyre DW;
    Nat Commun; 2024 Feb; 15(1):1008. PubMed ID: 38307854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.
    Flacco ME; Soldato G; Acuti Martellucci C; Di Martino G; Carota R; Caponetti A; Manzoli L
    Front Public Health; 2022; 10():884121. PubMed ID: 35586006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile.
    Mella-Torres A; Escobar A; Barrera-Avalos C; Vargas-Salas S; Pirazzoli M; Gonzalez U; Valdes D; Rojas P; Luraschi R; Vallejos-Vidal E; Imarai M; Sandino AM; Reyes-López FE; Vera R; Acuña-Castillo C
    Front Public Health; 2022; 10():984433. PubMed ID: 36339233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
    Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
    Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
    Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
    Cohen D; Izak M; Stoyanov E; Mandelboim M; Perlman S; Amir Y; Goren S; Bialik A; Kliker L; Atari N; Yshai R; Zaide Y; Marcus H; Madar-Balakirski N; Israely T; Paran N; Zimhony O; Shinar E; Maor Y; Muhsen K
    Int J Infect Dis; 2023 Jul; 132():72-79. PubMed ID: 37072052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.